TUCSON, Ariz., April 21, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced the sizeable release of new data presented by the company, its customers, and clinical experts during the ...
DUBLIN, Ireland and CHICAGO, April 20, 2023 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation oral ...
This Poster will be available on the Company’s website on the “Publications: Posters & Presentations” page under the “Our Science” tab. ORLYNVAH™ is a novel oral penem antibiotic for the treatment of ...
The poster will also be made available as an ePoster for viewing by delegates on the ECCMID virtual platform during ECCMID 2024 and in the publications section of the BiomX website. BiomX expects to ...
A scientific poster highlighting a novel pharmacologic property of oral ibezapolstat for C. difficile Infection likely related to its unique mechanism of action was presented at ECCMID 2023 An update ...
CHELMSFORD, Mass., May 21, 2020 /PRNewswire/ -- First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis of life-threatening, ...
All posters will be available to meeting registrants on demand through the ECCMID website. Following the meeting, the presentations will be available on the ContraFect website. Follow ContraFect on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results